^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG CLASS:

    DDR enhancer

    Related drugs:
    Apply
    PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications (NCT06161519)
    Phase 1/2
    National Cancer Institute (NCI)
    Recruiting
    Last update posted :
    06/05/2024
    Initiation :
    01/31/2024
    Primary completion :
    11/14/2028
    Completion :
    11/14/2033
    MYCN
    |
    MYCN amplification
    |
    PLX038